R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
| Title   | Location | Date | Req ID | |
|---|---|---|---|---|
| 
                                                                    
                                                                        Ad Promo Manager, Americas Regulatory Affairs, Global Rare Diseases
                                                                    
                                                                    
        
        
            Boston, MA, US
            
        
                                                                    Oct 26, 2025
													                
                                                                    6005
                                                     | ||||
| 
                                                                    
                                                                        Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
                                                                    
                                                                    
        
        
            Europe, IT
            
        
                                                                    Oct 23, 2025
													                
                                                                    6111
                                                     | ||||
 
                    